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INTRODUCTION
In 2007, Steven Avery was sentenced to prison for the murder of Teresa Halbach. What made this
case stand out was that Avery had recently been released from prison, after wrongfully spending
18 years incarcerated on a rape charge. Advances in DNA analysis were used to prove Avery’s
innocence, resulting in his release. Avery quickly filed a lawsuit against Manitowoc County and
former officials, whom Avery believed had framed him. In the midst of these procedures, Avery
was again arrested for murdering Halbach. His nephew, Brendan Dassey, was also arrested and
convicted as an accomplice.
The handling of the Halbachmurder case was highly controversial. Steven Avery and his lawyers
argued that they had he had once again been “set up” by his judicial adversaries. One central piece
of evidence incriminating Avery was the presence of his blood at the crime scene. Avery’s attorney’s
argued that the blood had been planted, arguing that the source was a test tube containing Avery’s
blood, which local police forces had access to.
But how determine if the crime scene blood was from a sample tube? The Avery tube contained
ethylenediamine-tetraacetic acid (EDTA), which prevents blood coagulation and degradation.
EDTA is not naturally present in human blood, and the defense argued that if EDTA was found
in the crime scene blood, it would prove the blood was planted. The results of this analysis has
generated vast discussion on social media and elsewhere, particularly following the documentary
Making a Murderer1, which describes the life and trials of the Avery family. However, tools of
forensics and chemical analysis are often “black boxes” to non-scientists, and perhaps early-stage
science students as well. Even for the most curious and inquisitive, it can be difficult to learn more
about these techniques, as they are mostly described in often-expensive scientific papers.
Therefore, we would like to here describe the central technique used for determining EDTA in
blood spots in the Avery case, namely liquid chromatography-mass spectrometry (LC-MS). We
here attempt to describe it in relatively simple terms. Please note that we will not discuss the
judicial aspects of the case, but merely describe a central scientific technique used in a trial that
has captivated and concerned millions of people.
LC-MS: THE MEASURING APPARATUS
LC-MS is a technique/apparatus that can be used for finding and measuring specific molecules in
a sample. These molecules can be big (e.g., proteins) or small (e.g., amino acids), fatty or water-
soluble. In other words, LC-MS is a versatile technique that can be used to search for a great variety
of molecules.
1http://www.netflix.com/no-en/title/80000770, Accessed August 2016.
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FIGURE 1 | Very simplified illustration of the LC-MS process.
Starting with the MS part: MS is an advanced instrument that
is typically the size of a washing machine. MS measurements
are used to calculate the mass of the molecules in a sample
(Maher et al., 2015). A human being can have a mass of e.g.,
75 kilos, but a single amino acid molecule has a mass of
about 0.00000000000000000000000003 kilos. Hence, the MS is
an extremely precise and accurate instrument that can be used
to pinpoint a molecule’s mass with great accuracy and precision.
Therefore, if the MS detects a molecule corresponding to the
mass of EDTA, there is already a fair chance that may be EDTA
is present in the sample. Rather than kilos or pounds, the mass
of a molecule is reported in daltons (Da); EDTA’s exact mass is
292.09 Da.
There are many kinds of MS instruments (Maher et al.,
2015). Some instruments determine the mass of a molecule by
measuring the speed in which it flies in the MS, or measuring
the frequency and radius in which it circles an electrode inside
the MS.
However, other molecules present in a sample may have the
samemass as EDTA2 (just like many humans weigh 75 kilos; how
could a balance tell them apart?). This presents a risk of a false
positive, i.e., believing you are measuring one molecule, while in
2http://www.chemspider.com/Molecular-Formula/C10H16N2O8, (Accessed
September 2016).
fact measuring another. Therefore, more steps can be taken to
ensure a valid analysis. One is that the MS instrument can feature
a collision cell, a chamber where molecules are bombarded with
gas, breaking the molecule into smaller pieces. The masses of the
pieces/fragments are then measured, and a computer visualizes
the fragments of the shatteredmolecule. This visualization (called
an “MS/MS spectrum”) can serve as a “fingerprint” of the
molecule. If a mass fingerprint is for a particular molecule is
observed, it serves as strong evidence that themolecule of interest
is indeed present. An example of an EDTA MS/MS fragment is
the mass 247.09, in which CO2 is chopped off the rest of the
molecule. For more details on mass spectrometric features of
EDTA (see e.g., Miller et al., 1997).
One problem with MS is that if you put a very complicated
sample (e.g., blood) in the instrument, it gets “too crowded”;
the MS might not be able to tell one molecule from the
other, or have trouble detecting molecules (Annesley, 2003). In
addition, one can be so unfortunate that two slightly different
molecules may have virtually the same fingerprint (Wilson et al.,
2010)!
This is where the LC part comes in; LC (Snyder et al., 2011)
is a technique that introduces different molecules from the
sample to the MS at different time points, so the MS has fewer
molecules to measure at a time. For example, the LC system
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may first permit very water-soluble molecules to enter the MS,
followed by semi-soluble molecules, followed by poorly-soluble
molecules, and so on. The LC forces the different molecules
in a sample to “stand in a queue, to wait for their turn for
entering theMS” (Figure 1). The time points in which a molecule
enters the MS from the LC (called the retention time), are very
precise, and can be used as additional grounds for identifying
a molecule in a sample. An LC-MS analysis typically lasts for a
few minutes or several tens of minutes, depending on e.g., the
sample’s complexity. If EDTA is present in a sample, its “mass
fingerprint” should be detected, and at a specific retention time.
When using LC-MS, an expert must manually analyze/confirm
this “fingerprint”, although computer programs can assist (but
not yet replace) this process. It is also important to compare a
“fingerprint” found in a sample with a pure chemical. This is
straightforward regarding EDTA, as it is commercially available
at high purity.
Before the LC-MS analysis can begin, the proteins in the blood
sample must be removed (proteins “stick to everything” and
can ruin the LC-MS instrument parts). For measuring EDTA in
blood, large proteins have typically been discarded using very fine
filters (Johnsen et al., 2016).
THE AVERY SAMPLES
Regarding the Avery samples, the FBI was unable to detect EDTA
using LC-MS3. It was concluded that EDTA was not in the
samples analyzed.
When reading the recently released FBI reports on the analysis
of Avery’s blood3,4, it seems that the LC-MS part has all in all
been suitably performed, with a number of steps taken to ensure
that false positives and negatives would not occur, e.g., use of
3http://www.stevenaverycase.org/wp-content/uploads/2016/01/Trial-Exhibit-
435-FBI-EDTA-Test.pdf, Accessed August 2016.
4http://www.stevenaverycase.org/wp-content/uploads/2016/01/Trial-Exhibit-
434-Analysis-of-EDTA-in-Dried-Bloodstains.pdf, Accessed August 2016.
“mass fingerprint”, retention time, addressing that EDTAbinds to
metals, and use of an “internal standard” (Dolan, 2012) (adding
andmonitoring a “twin” molecule of EDTA, which is used to spot
if anything has gone wrong with the analysis). The method does
not appear to be “thrown together”, but is based on a previous
method reported some years earlier (Miller et al., 1997). However,
it would have been desirable if control samples absorbed to
variety of absorbents (metal surfaces, wall paper, etc.) had been
investigated, to demonstrate the validity and robustness of the
total method.
Some limitations of the method are stated in the FBI
reports. One weakness is that the system can “only” detect
0.013mg of EDTA molecules per milliliter blood. In contrast,
other compounds can be readily identified at 1000 times
lower concentration or less. On the other hand, EDTA
concentrations are is expected to be about 100 times higher
than 0.013 milligrams of EDTA per milliliter blood (Miller et al.,
1997).
The LC-MS spectra (the “fingerprint”) is not presented,
making it difficult for viewers to acknowledge that there
is a 100% certainty that EDTA was not present in the
Avery blood stains. If these spectra were released for
external inspection, it could relieve suspicions of contextual
bias5. Another annoyance is that the report does not
state the specific brand and specifications of the mass
spectrometer used, which is a given to state in e.g., scientific
papers.
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